Endocrine disrupters (EDs) are chemicals found in the environment that mimic or modulate the physiological effects of endogenous hormones and that may contribute to adverse effects observed in wildlife and humans (National Research Council, 1999) . The National Toxicology Program has established an interagency agreement between the National Institute of Environmental Health Sciences and the National Center for Toxicological Research designed to evaluate the effects of a range of doses of endocrine disrupters on hormone-sensitive tissues over multiple generations in Sprague-Dawley rats. Among the compounds selected were genistein and p-nonylphenol. Genistein is a phytoestrogen found in manysoy products consumed by humans (Doerge et al., 2000a Strauss et al., 1998; Wu et al., 2004) , while p-nonylphenol is an intermediate used in the production of alkylphenol ethoxylate surfactants and plastics that can be released into the environment upon breakdown of these products (Doerge et al., 2002) .
Measurements of the anatomical development of hormonally sensitive and sexually dimorphic brain structures in rats, such as the SDN (Bleier et al., 1982; Gorski, 1985) , may be useful as biomarkers of the effects of exposure to endocrine disrupters. It is known that SDN structure may be altered following perinatal exposure to either estrogens or androgens; the androgens, however, must first be aromatized to estrogens in order to affect the rat SDN (Dohler, 1991) . An irreversible syndrome then follows estrogen exposure during a critical perinatal period. The typical pattern of development of ER-containing neurons of the SDN is altered, and a distinctive pattern of neurobehavioral changes takes place (Davis et al., 1995 (Davis et al., , 1996b .
Ordinarily, the female rat hypothalamus appears to develop according to an orchestrated removal of a number of its SDN neurons by programmed cell death, i.e., apoptosis (Davis et al., 1996a) . Suspension or reduction of this process of programmed cell death, such as may occur with exposure to estrogen or testosterone, results in the male pattern of hypothalamic development. However, females usually have little testosterone and their endogenous estrogen is excluded from the brain due to its forming a complex with the circulating steroid binding protein, a-fetoprotein (Milligan et al., 1998) . Thus their adult SDNs achieve the characteristically smaller female pattern during development.
The male rat hypothalamus maintains a large population of SDN neurons throughout development. Since their circulating testosterone is not bound to a-fetoprotein, it has access to the hypothalamus where a cytochrome P450 enzyme, CYP19 (Abdelgadir et al., 1997; Yamada-Mouri et al., 1995) , also known as ''aromatase,'' converts the testosterone to estrogen . In the ordinary course of events for male rats, their hypothalamic neuronal ERs then remain liganded with estrogen produced by the aromatization of their circulating testosterone. These liganded ERs form dimers that bind to nuclear estrogen response elements (EREs), which can then promote the synthesis of nerve growth factor(s) and/or their ''trk-A'' family (tyrosine kinase) receptors, which result in the down regulation of apoptosis (Gibbs, 1998; Toran-Allerand, 1996) . The result is the characteristically larger adult male rat SDN.
Under more extraordinary or experimental circumstances, the structure of the genetic female hypothalamus may become ''masculinized'' (Faber and Hughes, 1992; Lewis et al., 2003) . A masculinized female SDN may result from perinatal exposure to testosterone (which is aromatized to estradiol), by excessive levels of estrogen (more than can be bound by circulating a-fetoprotein), or by moderate amounts of any estrogenic compound that fails to bind to the protective a-fetoprotein.
The occurrence of a ''feminized'' SDN in a genetic male may likewise occur: insufficient testosterone (as a source of estrogen) may be available, aromatase activity may be suppressed, or estrogen receptors may be absent or blocked by an antagonist (Amin et al., 2000; Ogawa et al., 1997; Resko and Roselli, 1997) .
Finally, ''hypermasculinized'' genetic males, both behaviorally and neurologically, have been observed to occur when excessive testosterone or estrogenic compounds are present during development in songbirds (Mathews et al., 1988; Mathews and Arnold, 1991; Schlinger and Arnold, 1991) . Under such circumstances, apoptosis may be even more completely suppressed than in control males that have been exposed only to their own endogenous source of testosterone during development (Davis et al., 1996a; Levy et al., 1995) . However, studies of estrogenic or androgenic compounds in male rats have not usually observed an enlargement of the SDN (Faber and Hughes, 1991; Nagao et al., 1999; Register et al., 1995) .
Changes in the reproductive function and behavior of rats who have undergone masculinization or feminization of the SDN have also been reported (Ogawa et al., 1997; Rhees et al., 1999) . Masculinization of genetic female rats results in delayed and more difficult induction of sexual receptivity (lordosis). Feminization of genetic male rats may slow or prevent them from mounting a stimulus female rat or increase the probability that they will exhibit the female pattern of lordosis after appropriate hormonal priming. Less is known about functional changes in adult hypermasculinized male rats.
Toxicological studies of endocrine disrupters have attempted to utilize measurements of the SDN as biomarkers of developmental exposure, with variable results. In female rats, injections of 500 or 1000 mg/day genistein sc during postnatal days 1-10 increased the SDN volume while there were no significant effects on males Hughes, 1991, 1993) . With prenatal administration of 5000 mg/day genistein to the dam, a decrease in SDN volume in females was observed (Levy et al., 1995) . A study of prenatal exposure through the maternal diet beginning on GD 7, followed by postnatal lactational exposure of the offspring and continued exposure after weaning until PND 50 reported that both genistein and nonylphenol decreased SDN volumes in males, but was without effect in females Slikker et al., 2001) . Genistein at 40 mg/kg, but not 4 mg/kg, given sc on PND 1-7 as well as po from PND 8-21 increased the female, but not the male, SDN size (Lewis et al., 2003) . This study, using a partially overlapping period of developmental exposure and the same route of genistein administration at least for PND 1-7, revealed an increase in female SDN volume, as previously reported Hughes, 1991, 1993) . Dietary exposure of dams to up to 1000 ppm of genistein (Masutomi et al., 2003) and up to 3000 ppm of bisphenol-A and nonylphenol (Takagi et al., 2004) from GD 15 through postnatal day 10 was without effect on the SDNs of either males or females. Exposure to up to 320 mg/kg/ day of bisphenol-A po from GD 11 through PND 20 was also without effect on the volume of the SDN (Kwon et al., 2000) , as was bisphenol-A given at a dose of 300 mg/kg sc from postnatal days 1-5 (Nagao et al., 1999) . These studies may be inconclusive due to wide differences between protocols in the developmental timing and route of administration of the compounds as reviewed above. In addition, measurement of the SDN volume is technically difficult, as is apparent from the wide variability reported both within and between laboratories, as previously reviewed (Meredith et al., 2001) .
Recently, immunohistochemical labeling of calbindin D28k was shown to identify a subpopulation of neurons within the SDN, called the CALB-SDN, that could be measured with less variability than Nissl-stained SDN neurons (Lephart et al., 1998; Sickel and McCarthy, 2000) . The calbindin-labeled neuronal population, like Nissl-stained SDN neurons, increased in volume when exposed to perinatal testosterone or estradiol, and proceeded through early development at about the same rate.
Since SDN volume has often been used as a biomarker of estradiol or ED exposure Hughes, 1991, 1993; Ferguson et al., 2000b; Kwon et al., 2000; Masutomi et al., 2003; Nagao et al., 1999; Register et al., 1995; Slikker et al., 2001; Vancutsem and Roessler, 1997) , we thought the volume of the calbindin D28k immunoreactive SDN (CALB-SDN) neurons (Taylor et al., 1999; Sickel and McCarthy, 2000) might also comprise a suitable biomarker of exposure to estrogenic endocrine disruptors. For this purpose, a desirable method of measuring calbindin immunoreactive SDN volume should provide reproducible, accurate, and unbiased measurements suitable for statistical analysis, with sufficient ease and rapidity so that a large number of brains can be processed. We developed an approach utilizing the methodology of 3-D reconstruction to provide quantitative estimates of the volume of the CALB-SDN in experimental animals (Meredith et al., 2001) . As a test of the practical application of these methods, we measured the CALB-SDN of rats following lifetime dietary exposure to either genistein or para-nonylphenol.
MATERIALS AND METHODS
Animals and groups. All animal handling and treatment procedures were approved by the NCTR Institutional Animal Care and Use Committee. Female adult Sprague-Dawley rats were date-mated in the NCTR breeding colony. Experimental dietary exposure to genistein (10 control litters and 10 litters per dose group) or p-nonylphenol (10 control litters and 10 litters per dose group) began by adding the endocrine disrupters to the dams' chow 28 days prior to mating. The chow contained either control levels of genistein or p-nonylphenol (less than 1 ppm), or were supplemented to final concentrations of 5 ppm, 100 ppm, or 500 ppm for genistein or 25 ppm, 200 ppm, or 750 ppm for p-nonylphenol. Offspring were culled to four males and four females per litter on postnatal day 2 (PND 2), and the dams remained on the experimental diets throughout lactation, whereupon the offspring were continued on the same diets until they were sacrificed (gonadally intact) at 140 days of age (PND 140). All female rats were cycling at this age, but the stage of estrus was not taken into account in the neurohistochemical analyses of the animals. One male and one female rat from each litter were designated for 3-D reconstruction of the CALB-SDN: no two same-sexed rats of a treatment group were from the same litter. The AALAC-approved vivarium was maintained under controlled environmental conditions (temperature 22 C, relative humidity 50%, 12 h light:dark cycle with lights out at 1800 h); rats were housed in plexiglas cages with hardwood chips for bedding. Water and experimental rat diets were available ad libitum.
Chemical Exposures
Control diet. The basal (control) diet was irradiated 5K96 meal that contains 3.13 kcal/g, 20% protein, 3.8% fiber, and 4.6% fat (Purina Mills Inc., St. Louis, MO). This diet is similar to the standard NIH 31 except that the soymeal and alfalfa components were replaced by casein and soy oil was replaced by corn oil. The genistein (0.54 mg/g) and daidzein (0.48 mg/g) content in this feed was determined using Liquid Chromatography/ElectroSpray/Mass Spectroscopy analysis after complete hydrolysis of glucoside conjugates (Doerge et al., 2000b) .
Genistein. Genistein was obtained from Toronto Research Chemicals (Ontario, Canada) with purity greater than 99% as determined from 1 H-and 13 C-Nuclear Magnetic Resonance, Electron Ionization/Mass Spectrometry, melting point, and Thin Layer Chromatography analyses.
P-nonylphenol. Nonylphenol, obtained from Schenectady International (Schenectady, NY), consisted of 95% branched side chain isomers of 4-NP and 5% of branched side chain isomers of 2-NP as determined using 1 H-and 13 C-NMR. Choice of doses. Complete details regarding feed consumption and body weights from a related dose range-finding study have been published elsewhere . The doses of genistein used in the present study covered the dose range used in previous studies Ferguson et al., 2002; Flynn et al., 2000a,b) so that the CALB-SDN results could be compared to other known effects of genistein. The doses of p-nonylphenol employed here were the same as doses used in previous studies of other endpoints (Doerge et al., 2002; Ferguson et al., 2002) .
Treatment groups. Forty dams were exposed to genistein and forty dams to p-nonylphenol in their chow beginning 28 days prior to being mated. Four groups of male rats (n 5 10) and four groups of female rats (n 5 5) from independently dosed litters were then continuously exposed either to genistein (control, 5 ppm, 100 ppm, or 500 ppm) or p-nonylphenol (control, 25 ppm, 200 ppm, or 750 ppm) added to their dam's chow throughout gestation and lactation and to their own chow from the time of weaning until sacrifice at PND 140. Fewer female rats per group were designated for CALB-SDN measurements because our previous work Slikker et al., 2001) had indicated that the effects of genistein were restricted to males.
Tissue preparation. Brain tissue was collected from 120 gonadally intact Sprague-Dawley rats sacrificed by asphyxiation at 140 days of age. Tissues were postfixed in 4% formaldehyde at 22 C until further processing. These rat brains were obtained from the F1 generation of multigenerational studies conducted at NCTR, and additional details of the experiments are available (Ferguson et al., 2002; Flynn et al., 2000b) .
The brains were placed in a stainless steel coronal brain matrix (Ted Pella, Inc., Redding, CA) and the slab containing the sexually dimorphic region of the hypothalamus (Paxinos and Watson, 1986 ) was removed using a single-edged razor blade. The resulting slab of tissue was then mounted on a rubber block and immersed in phosphate buffer for sectioning with a vibrating microtome.
Tissue sectioning and staining. Briefly, forty mm thick serial sections were cut using a vibrating microtome (The Vibratome Company, St. Louis, MO). Sections were rinsed three times for 5 min each in 0.1 M phosphate buffer (pH 7.4). The sections were then kept free-floating overnight in 24-well baskets at 5 C in rabbit anti-calbindin D28k primary antisera (Sigma Chemical Company, St. Louis, MO) diluted 1:500 in antibody diluent (Scallet, 1995; Scallet et al., 1988) . The next day they were rinsed in 0.1 M phosphate buffer and incubated for 1 h in goat anti-rabbit secondary antisera (Jackson Immuno Research, West Grove, PA) diluted 1:100 in antibody diluent. Finally, they were rinsed again in buffer and incubated for 1 h in rabbit peroxidase/anti-peroxidase complex (Jackson ImmunoResearch, West Grove, PA) diluted 1:100 in buffer. They were then rinsed again and stained for 10 min using diaminobenzidine (DAB, Sigma Chemical Company, St. Louis, MO) as substrate for the peroxidase. The DAB creates a brown stain where the primary antisera was localized. Finally, the sections were mounted on glass slides and coverslipped with Permount.
Three-dimensional reconstruction. Briefly, the imaging system was calibrated by using a certified measurement standard which was digitally photomicrographed using each microscope objective (Meredith et al., 2001) . Then the known length (in mm) of the line on the measurement standard was divided by the number of pixels (individual data points forming the digital image) corresponding to that length. From the number of mm per pixel, the volume of a ''voxel'' (cubical pixel) can then be determined by cubing the length of a single pixel. With the computer mouse, outlines were drawn around the immunolabeled calbindinpositive cells in each section (see Fig. 1) . The tracings were then filled to facilitate the three-dimensional reconstruction. A computer generated three-dimensional rendering containing the calbindin-positive cells was then created from a stack of about 4-6 sequential sections. Volume measurements of the calbindin-positive neurons within the SDN were obtained as the number of voxels, times the size of each voxel in cubic microns, that were contained within the surface rendered over the calbindin-positive cell group outlined within the SDN (see Figs. 1e and 1f) . To validate this method, a set of 10 different animals with obscured identifications was reconstructed by two independent observers (A.C.S. and B.L.D.), with the resulting inter-rater correlation coefficient of r 5 0.949, p 5 0.0001.
Statistical analysis. Two-way analyses of variance (SigmaStat, Cary, NC) were performed on the volume data from each experiment (genistein and nonylphenol), with dose of the endocrine disrupter (four levels) and sex (two levels) as factors. In the presence of a significant Main or Interaction effect by ANOVA, Fisher's Least Significant Difference (LSD) post hoc tests comparing individual means were carried out. Results were considered significant at p 5 0.05.
RESULTS

Variability of Calb-SDN Volume Measurements in Controls
The variance in male control animals of the present study was about 9.84 mm 3 3 10 6 , while the variance for control females was about 1.47 mm 3 3 10 6 .
Genistein
Genistein exposure caused a significant increase in the volume occupied by the calbindin-immunopositive neurons within the SDN (F(3,52) 5 4.3, p 5 0.01). There was also a significant difference between the sexes (F(1,52) 5 62.2, 572 SCALLET ET AL. p 5 0.001). Although the interaction between genisteintreatmentandsexwas notstatisticallysignificant(F(3,52)52.00, p 4 0.10), individual post-hoc tests (see Fig. 2 ) indicated that the effects of genistein exposure were restricted to the males. The CALB-SDNs of the genistein-treated female groups were not significantly different in volume from their female control group (all p's 4 0.10).
Nonylphenol
Nonylphenol exposure did not significantly increase the volume occupied by the calbindin-immunopositive neurons within the SDN (F(3,52) 5 1.9, p 4 0.10). However, there was a significant difference between the sexes (F(1,52) 5 45.5, p 5 0.001). Although the interaction between genisteintreatment and sex was not statistically significant (F(3,52) 5 1.2, p 4 0.10), individual post-hoc tests (see Fig. 3 ) indicated that the 25 ppm and 200 ppm groups of males were significantly 
FIG. 2.
The effects of lifetime dietary exposure to genistein on the volume of the CALB-SDN. A dose-related increase occurred in the males (*indicates p 5 0.01 greater than the male control group), but the females, though significantly smaller in volume than the males ( p 5 0.001), showed no effect of treatment with genistein ( p 4 0.10).
FIG. 3.
The effects of lifetime exposure to p-nonylphenol on the volume of the CALB-SDN. An inverted-U pattern of increase occurred in the males (*indicates p 5 0.01 greater than the male control group), but the females, although significantly smaller in volume than the males ( p 5 0.001), showed no effect of treatment with p-nonylphenol ( p 4 0.10).
GENISTEIN AND NONYLPHENOL INCREASE VOLUME OF THE CALB-SDN 573 larger than the male controls ( p's 5 0.01). The CALB-SDN volume of the 750 ppm group was not different from controls ( p 4 0.10), suggesting an ''inverted U'' shaped dose-response relationship. The CALB-SDNs of the nonylphenol-treated female groups were not significantly different in volume from their female control group (all p's 4 0.10).
DISCUSSION
Visual Representation and Measurement of the CALB-SDN Portion of the Hypothalamus
We have delineated the calbindin-immunopositive neurons within the anterior ventral hypothalamic area of both male and female rats (Fig. 1) . In addition to visualizing these structures three-dimensionally, the volume of the CALB-SDN was measured based on the computer's summation of the total number of voxels contained in the rendered object times the calibrated volume of each voxel. There was a clear sexual dimorphism in the computed CALB-SDN volumes: male CALB-SDNs were 3 times larger than their female counterparts in both experiments. This ratio is similar to what has typically been reported for the Nissl-stained rat SDN in previous studies (Meredith et al., 2001) . Moreover, the variance that we measured in the present study for the volume of the CALB-SDN of male control rats (9.84 mm 3 3 10 6 ) was smaller than the variances for the Nissl-SDN that were reported in six out of the nine studies reviewed previously (Meredith et al., 2001) . Similarly, the variance of the mean of the CALB-SDN measured in our female rats (1.47 mm 3 3 10 6 ) was smaller than the variances for the Nissl-SDN, but only in three out of the seven studies reviewed. Future studies will be required to determine whether the means for SDN volume as determined using the CALB-SDN methodology are a more accurate or reproducible biomarker of ED exposure than measurement of the Nissl-stained SDN.
Genistein
In the present study, there is a rather clear enlargement of the CALB-SDN in male rats with increasing lifetime dietary exposure to genistein. Given the estrogenic properties of genistein, this observation may correspond to a previous report of increased calbindin content of the medial basal hypothalamic preoptic area (MBH-POA) of prepubertal male rats treated with estrogen, as measured by Western blots (Stuart et al., 2001) . However, it fails to correspond to the observation that, in the adult male rat, phytoestrogen exposure decreased calbindin content in the MBH-POA by Western blot (Lephart et al., 2000) . These observations taken together may indicate that in life-long exposures of male rats to estrogenic compounds, the perinatal exposure ''trumps'' the adult exposure and exerts the ultimate controlling influence on the MBH-POA content of calbindin.
It indicates that the occurrence of a "hypermasculinized" rat may be expected with lifetime exposure to genistein, such as might be expected from excessive activation of hypothalamic estrogen receptors during the perinatal period.
P-Nonylphenol
As with genistein, p-nonylphenol appeared to increase the size of the CALB-SDN, at least at the intermediate doses used here. There was a suggestion of a plateau or reduction of activity at the highest dose of p-nonylphenol (750 ppm). Taken together with the genistein data, it appears that lifetime dietary exposure to endocrine disrupters with estrogenic activity may result in an enlarged CALB-SDN and a ''hypermasculinized'' male. The functional consequences of these effects are uncertain, as neither compound was observed to effect sexually dimorphic behaviors such as open field or running wheel activity Flynn et al., 2000a) , nor did they alter play behavior Flynn et al., 2000a) or the nursing behavior of dam/offsping dyads . The most consistent functional effect of these endocrine disrupters was an increased intake of sodium chloride solutions Flynn et al., 2000a) , probably mediated by increased hypothalamic vasopressin (Scallet et al., 2003) , but these effects occurred in both males and females and thus are unlikely to be related to the "hypermasculinization" effect of estrogenic endocrine disrupters on the male CALB-SDN. It appears from a careful review of the literature that variations in the precise timing of the exposure to an ED, e.g., pregestational (which may influence the capacity of the maternal binding proteins), gestational, perinatal, prepubertal, or adult) and the various routes of administration (SC, PO, lactational, through the chow) may have contributed to the variability of results obtained. Very few studies have employed exactly the same exposure procedures. Perhaps the CALB-SDN measurement procedures will help contribute to resolving these differences.
